Tokyo, Jan. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058082) titled 'Evaluation of high-dose aflibercept therapy, aqueous humor cytokine changes, and prognostic factors in patients with age-related macular degeneration' on Jan. 1.
Study Type:
Observational
Primary Sponsor:
Institute - Nagoya University Hospital
Condition:
Condition - Neovascular age-related macular degeneration
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study aims to evaluate the efficacy of high-dose aflibercept therapy for neovascular age-related macular degeneration and to analyze cytokine concentrations in aqueous humor obtained at the initiation of tr...